Back to UBS Group AG UBS Group AG

VRCAVRCA
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in VERRICA PHARMACEUTICALS INC

UBS Group AG holds 6,071 shares of VRCA (VERRICA PHARMACEUTICALS INC), worth $37,155 as of 2026-Q2. The position was increased (+42.2% shares).

Current Value

$37,155

Current Shares

6,071

Total Value Change

-$142,279

Total Shares Change

-35,561

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6,071
+42.2%
$37,1550.0%$6.12
18
2026-Q1
Increased
4,270
+177x
$22,5880.0%$5.12
21
2025-Q4
Decreased
24
-99.9%
$1990.0%$8.30
0
2025-Q3
New
41,632
-
$179,4340.0%$4.30
35

Other major holders of VRCA: VANGUARD CAPITAL MANAGEMENT LLC, Mariner, LLC, VANGUARD GROUP INC, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used